Publication

Article

CURE

Breast Cancer Special Issue
Volume1
Issue 1

Medical Illustration: Breast Cancer

Author(s):

Pam Curry

Certain drugs target estrogen receptor-positive or HER2-positive breast cancers. Research is examining whether better drugs or combinations can improve outcomes.

Certain drugs target estrogen receptor-positive or HER2-positive breast cancers. Research is examining whether better drugs or combinations can improve outcomes.

Click to download/enlarge

Click to download/enlarge

Click to download/enlargeILLUSTRATION BY PAM CURRY, ORIGINALLY PUBLISHED IN “A NEW ERA,” CURE SPECIAL ISSUE: ADVANCES IN BREAST CANCER 2007

Chemotherapy drugs are also commonly used to treat different types of breast cancer. Chemotherapy kills cells that are in the process of dividing; in adults, that most often means cancer cells. Chemotherapy drugs work by inhibiting the creation of nucleotides that are needed for DNA formation, by damaging the DNA itself, or by halting mitosis, the process by which the chromosomes containing DNA physically divide. These drugs as not as specific as hormonal or HER2-targeted therapies and can injure normal cells to a greater extent, and therefore tend to cause more side effects.

Articles in this issue
A Worthwhile Investment
Getting Personal
Mustering the Courage to Decide on Treatment
Medical Illustration: Breast Cancer
Positive Energy: Preventing Local Recurrence of Breast Cancer With Radiation
On the Fence: The Pros and Cons of Breast Screening
A Different World: Metastatic Breast Cancer
Considerations for Breast Reconstruction Surgery
Lumpectomy or Mastectomy for Localized Breast Cancer: A Personal Decision
Breast Cancer Treatment Plan Should Include Weight Management
Preventive Drugs Keep Cancer "and Fear" Away
Improving Outcomes and Accommodating Preferences in Earlier-Stage Breast Cancer
Angelina Jolie Sparks Rise in Genetic Testing for Treat Breast Cancer
Related Videos
Image of Doctor.
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
Image od grey haired Doctor.
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
Image of man with grey hair.
Image of woman with blonde hair.
Image of woman with blonde hair.
Related Content
Childhood cancer survivors are at risk of experiencing onset of aging-related disease 17.7 years sooner than the general population: © Konstantin Yuganov - stock.adobe.com
March 28th 2025

Childhood Cancer Survivors May Experience Sooner Aging-Related Disease

Alex Biese
Researchers have found childhood cancer survivors are at risk of experiencing onset of aging-related disease 17.7 years sooner than the general population.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Illustration of woman with grey hair.
March 26th 2025

Surviving Scans While Surviving Breast Cancer

Felicia Mitchell
Survivors facing new medical concerns may fear the unknown, but perseverance is possible as they navigate unexpected challenges in their new normal.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Image of a pink ribbon.
March 21st 2025

Advancing ctDNA for Minimal Residual Disease Detection in Breast Cancer

Ryan Scott
Dr. Debu Tripathy explains how ctDNA is used to in breast cancer detection and how it can also indicate the presence of MRD.
Image of woman with pink ribbon.
March 20th 2025

Evolving Treatments and Advances in HER2-Positive Breast Cancer

Ryan Scott
Dr. Sara M. Tolaney discussed HER2-positive breast cancer, highlighting key trials, evolving treatment strategies, and the potential for improved outcomes.